For CRISPR/Cas-related technologies we offer the following services: 

• In vitro activity testing of sgRNAs
• Determination of genome editing efficiency
  • T7 endonuclease I (T7EI) to detect mismatches  
  • TIDE assay to track InDels
• Bioanalysis of sgRNA and Cas9 mRNA in blood and tissue (under GLP/GCP)